Has anyone tried #Journavx for pain?

Just got an rx called in..

Tell me about it please 🙏🏻!!

⬇️

#GoodRx shows #Journavx 50mg, 30 tablets, for as little as $30 per fill in GA.

@GoodRx shows #Journavx 50mg, 30 tablets, for as little as $30 per fill in GA.

Pioneering Pain Relief Research Earns 2026 Sharpey-Schafer Prize for Dr. Waxman Dr. Stephen Waxman, with support from Paralyzed Veterans of America, wins 2026 Sharpey-Schafer Prize for revolutionary pain relief research and non-addictive medication.

Pioneering Pain Relief Research Earns 2026 Sharpey-Schafer Prize for Dr. Waxman #USA #Washington #Paralyzed_Veterans #Journavx #Dr._Stephen_Waxman

The first non-opioid painkiller Journavx was approved this year. Why did it take so long to develop?

Fascinating news!

First painkiller that's NOT opioid/related

#suzetrigine aka #Journavx works backwards
blocking pain signals from being transmitted in the first place

instead of blocking receptors

Unfortunately not yet tested/approved for chronic pain

and since no generic, for now expensive

saw #Journavx for the first time in the pharmacy recently.

we had prepared a 30-count bottle of the 50 mg tablets (i don't remember if that was a 30-day supply or how the directions were written).

not covered by their insurance, the final cost to the patient was over $500 using a discount card;

Painkillers without the addiction? The new wave of non-opioid pain relief Pharma firms are developing drugs that avoid the brain’s opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced

#pain #nonopioidpainrelief #drugdevelopment #suzetrigine #VertexPharmaceuticals #Vertex #Journavx #nonaddictivepainkiller #nociceptivepain #neuropathicpain #Nociplasticpain #chronicpain #dopamine #dopaminedump #VertexPharmaceuticals #TrisPharma #Vertanical
www.theguardian.com/science/2025...

Journavx: Long awaited non-opioid treatment for acute pain hits the market FDA-approved Journavx (suzetrigine) could replace opioids for acute pain. Learn how it works, what it costs and when it can be used.

#Journavx: Long awaited non-opioid treatment for acute pain hits the market: www.uchealth.org/today/journa...

I doubt there is, but you never know. I sent a message through the portal afterwards with the question. Now, come on #journavx, need you in pharmacies so I can try. 🤞🍀

No Opioids, No Addiction: FDA Approves First New Type of Painkiller in Decades Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive.

This is really a big deal: No Opioids, No Addiction: FDA Approves First New Type of Painkiller in Decades https://buff.ly/4hTykIo #newpainkiller #painkiller #suzetrigine #journavx

The FDA has approved #Journavx (suzetrigine), a first-in-class non-opioid analgesic, for treating moderate to severe acute pain in adults offering an alternative to opioids for pain management.

Read more here: www.fda.gov/news-events/...

#PainManagement #OpioidAlternatives #Breakthrough #Vertex

The Price of Pain: What Will Journavx Cost Patients? How much is pain worth to the pharmaceutical industry? There's a new non-opioid pain pill called Journavx. How good is it? What's the price?

The Price of Pain: What Will Journavx Cost Patients? www.peoplespharmacy.com/articles/the... via @peoplespharmacy

#Journavx #pain #painkillers #nonopoidpainkillers #health

Neues Schmerzmittel: Anfang vom Ende der Opioid-Ära? FDA genehmigt Mittel gegen Schmerzen. Das Mittel wirkt anders als Opioide und macht nicht süchtig. Kann es der Befreiungsschlag gegen die Opioidkrise sein?

Neues #Schmerzmittel: Anfang vom Ende der #Opioid-Ära?

#Zulassung
#USA
#Journavx
#FDA

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk (Gift Article) The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

#FDA OKs Painkiller Without Addiction Risk. Suzetrigine, sold as #Journavx, works on nerves outside the brain, blocking pain signals. It cannot get into the brain.

USA lassen erstmals seit Jahrzehnten Schmerzmittel mit neuer Wirkweise zu Silver Spring – Erstmals seit mehr als 2 Jahrzehnten hat ein Schmerzmittel aus einer neuen Wirkstoffklasse in den USA eine Zulassung erhalten. Die...

Kampf gegen Opioid-Krise

Die FDA unterstützt die Entwicklung von nicht opioiden #Schmerzmitteln, auch um der Opioidkrise in den USA Herr zu werden. #Opioide sind beispielsweise nach Operationen oder bei der Krebsbehandlung nahezu unver­zichtbar.

#Journavx #Suzetrigin

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

New 1st in class, non opiate nonNSAID ,

#peripheral #Pain medicine : #Journavx #suzetrigine

Might be kidney processed.

www.nytimes.com/2025/01/30/h...

#CPP #SFN #SmallFiberNeuropathy #DisabilitySky #NEisvoid

#Fibro #Neuropathy

FDA approves new, non-opioid painkiller Journavx - The Washington Post
Source: The Washington Post Journavx

FDA on Thursday approved #Journavx, a non-opioid painkiller.
First in 20 years
#Vertex Pharmaceuticals has billed it as an effective alternative to opioids that isn’t addictive. Journavx works by intercepting pain signals before they reach the spinal cord, rather than acting directly on the brain.

FDA Approves Journavx, First New Non-Opioid Pain Pill in Decades - Drugs.com MedNews The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin a

FDA approves #Journavx, a non-addictive pain medication that blocks pain signals before they reach the brain. While less potent than opioids, it offers a safer alternative for post-surgery/injury pain. Developed by Vertex Pharmaceuticals (via AP).

FDA approves first new type of pain medication in 25 years - CNN
Source: CNN Journavx

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

U.S. FDA Approves Drug to Treat Pain Without Opioid Effects. The drug, #Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it non-addictive. It's also expensive: $15.50 per pill, by Gina Kolata www.nytimes.com/2025/01/30/h... via @nytimes.com

FDA approves first new type of pain medication in 25 years | CNN A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

🩺FDA approves first new type of pain medication in 25 years
#FDA #Journavx
www.cnn.com/2025/01/30/h...

FDA approves new painkiller that shows promise and challenges of opioid alternatives WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin...

"Federal officials [in the #USA] approved a new type of pain drug designed to eliminate the risks of #addiction and #overdose associated with #opioid medications like #Vicodin and #OxyContin" #Journavx vancouver.citynews.ca/2025/01/30/f...

FDA's Approval of Journavx Marks a Significant Advancement in Pain Management Without Opioids The FDA has approved Journavx, a groundbreaking non-opioid treatment for managing acute pain, offering a new alternative to traditional analgesics. This approval emphasizes the commitment to safer pain management solutions.

FDA's Approval of Journavx Marks a Significant Advancement in Pain Management Without Opioids #USA #FDA #Silver_Spring #Journavx #Vertex_Pharmaceuticals